These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
904 related items for PubMed ID: 23313376
1. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway. Liu Y, Wang L, Wu Y, Lv C, Li X, Cao X, Yang M, Feng D, Luo Z. Toxicology; 2013 Feb 08; 304():120-31. PubMed ID: 23313376 [Abstract] [Full Text] [Related]
2. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention. He P, Li Y, Hu J, Deng B, Tan Z, Chen Y, Yu B, Dong W. Phytomedicine; 2024 Jun 08; 128():155316. PubMed ID: 38518635 [Abstract] [Full Text] [Related]
3. 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells. Yun HM, Park KR, Quang TH, Oh H, Hong JT, Kim YC, Kim EC. Arch Pharm Res; 2017 May 08; 40(5):601-609. PubMed ID: 28386742 [Abstract] [Full Text] [Related]
4. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells. Su JC, Lin KL, Chien CM, Chuang PW, Chang LS, Lin SR. Clin Exp Pharmacol Physiol; 2010 Aug 08; 37(8):833-40. PubMed ID: 20456425 [Abstract] [Full Text] [Related]
5. Pterostilbene Inhibits the Growth of Human Esophageal Cancer Cells by Regulating Endoplasmic Reticulum Stress. Feng Y, Yang Y, Fan C, Di S, Hu W, Jiang S, Li T, Ma Z, Chao D, Feng X, Xin Z, Pang S, Li X, Yan X. Cell Physiol Biochem; 2016 Aug 08; 38(3):1226-44. PubMed ID: 26982591 [Abstract] [Full Text] [Related]
6. Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway. Du W, Hong J, Wang YC, Zhang YJ, Wang P, Su WY, Lin YW, Lu R, Zou WP, Xiong H, Fang JY. J Cell Mol Med; 2012 Aug 08; 16(8):1878-88. PubMed ID: 22050790 [Abstract] [Full Text] [Related]
7. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. Zhang T, Jiang B, Zou ST, Liu F, Hua D. World J Gastroenterol; 2015 Feb 14; 21(6):1804-13. PubMed ID: 25684945 [Abstract] [Full Text] [Related]
8. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma. Oh HN, Oh KB, Lee MH, Seo JH, Kim E, Yoon G, Cho SS, Cho YS, Choi HW, Chae JI, Shim JH. Phytomedicine; 2019 Jan 14; 52():60-69. PubMed ID: 30599913 [Abstract] [Full Text] [Related]
9. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway. Park KR, Yun HM, Quang TH, Oh H, Lee DS, Auh QS, Kim EC. Oncotarget; 2016 Feb 09; 7(6):6960-71. PubMed ID: 26755649 [Abstract] [Full Text] [Related]
10. Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway. Oh HN, Seo JH, Lee MH, Kim C, Kim E, Yoon G, Cho SS, Cho YS, Choi HW, Shim JH, Chae JI. J Cell Biochem; 2018 Dec 09; 119(12):10118-10130. PubMed ID: 30129052 [Abstract] [Full Text] [Related]
11. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling. Fu LX, Lian QW, Pan JD, Xu ZL, Zhou TM, Ye B. J Biol Regul Homeost Agents; 2017 Dec 09; 31(1):51-58. PubMed ID: 28337870 [Abstract] [Full Text] [Related]
12. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma. Yan J, Wang Q, Zou K, Wang L, Schwartz EB, Fuchs JR, Zheng Z, Wu J. Mol Med Rep; 2015 Jul 09; 12(1):498-502. PubMed ID: 25760445 [Abstract] [Full Text] [Related]
13. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells. Cheng Y, Cai L, Jiang P, Wang J, Gao C, Feng H, Wang C, Pan H, Yang Y. Eur J Pharmacol; 2013 Sep 05; 715(1-3):219-29. PubMed ID: 23726949 [Abstract] [Full Text] [Related]
14. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways. Zuo D, Zhou Z, Wang H, Zhang T, Zang J, Yin F, Sun W, Chen J, Duan L, Xu J, Wang Z, Wang C, Lin B, Fu Z, Liao Y, Li S, Sun M, Hua Y, Zheng L, Cai Z. J Cell Mol Med; 2017 Feb 05; 21(2):208-221. PubMed ID: 27624867 [Abstract] [Full Text] [Related]
15. Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS. Liang JR, Yang H. Biomed Pharmacother; 2020 May 05; 125():109585. PubMed ID: 32106377 [Abstract] [Full Text] [Related]
16. Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells. Park KW, Kundu J, Chae IG, Kim DH, Yu MH, Kundu JK, Chun KS. Int J Oncol; 2014 Apr 05; 44(4):1309-15. PubMed ID: 24481553 [Abstract] [Full Text] [Related]
17. TAT-mediated delivery of neuroglobin attenuates apoptosis induced by oxygen-glucose deprivation via the Jak2/Stat3 pathway in vitro. Lin Y, Cai B, Xue XH, Fang L, Wu ZY, Wang N. Neurol Res; 2015 Jun 05; 37(6):531-8. PubMed ID: 25023896 [Abstract] [Full Text] [Related]
18. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway. Jia F, Liu Y, Dou X, Du C, Mao T, Liu X. Oxid Med Cell Longev; 2022 Jun 05; 2022():8245614. PubMed ID: 35116094 [Abstract] [Full Text] [Related]
19. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway. Kim DH, Park JE, Chae IG, Park G, Lee S, Chun KS. Oncol Rep; 2017 Jul 05; 38(1):575-583. PubMed ID: 28560439 [Abstract] [Full Text] [Related]
20. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway. Huang L, Huang Z, Lin W, Wang L, Zhu X, Chen X, Yang S, Lv C. Int J Oncol; 2019 Jun 05; 54(6):1969-1980. PubMed ID: 31081055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]